Expanding Therapeutic Options for Patients with Lung Adenocarcinomas Using Oncomine Comprehensive Panel

被引：0
|
作者：
Park, Kyung
Tian, Hung
Feng, Xiaojun
Rubin, Mark A.
Fernandes, Helen
机构：
[1] Weill Cornell Med, New York, NY USA
[2] Englander Inst Precis Med, New York, NY USA
来源：
MODERN PATHOLOGY | 2017年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1852
引用
收藏
页码：461A / 461A
页数：1
相关论文
共 50 条
  • [21] Increasing targeted therapy options for mCRPC patients using multigene NGS panel
    Meintani, Angeliki
    Papadopoulou, Eirini
    Tsaousis, Georgios
    Tsantikidi, Aikaterini
    Metaxa-Mariatou, Vasiliki
    Kapetsis, Georgios
    Chatzigiannidou-Florou, Chrysiida
    Maxouri, Stella
    Floros, Theofanis
    Letsa, Ioanna
    Tansan, Sualp
    Militaru, Claudia
    Karalis, Konstantinos
    Ozdogan, Mustafa
    Efstathiou, Eleni
    Boukovinas, Ioannis
    Trougkakos, Ioannis
    Kollia, Panagoula
    Agathangelidis, Andreas
    Nasioulas, George
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] NGS-Molecular Characterization of Lung Adenocarcinomas from Hispanic Patients: Level of Evidence for Therapeutic Actionability
    Arrieta, O.
    Gerson, R.
    Blanco, C.
    Alexander Meza, J.
    Silva, A.
    Rivera Rivera, S.
    Zuloaga, C.
    Lazaro, M.
    Kazakova, E.
    Villa, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1186 - S1186
  • [23] NGS-Molecular Characterization of Lung Adenocarcinomas from Hispanic Patients: Level of Evidence for Therapeutic Actionability
    Arrieta, O. G.
    Gerson, R.
    Blanco, C.
    Alexander Meza, J.
    Silva, A.
    Rivera Rivera, S.
    Zuloaga Fernandez, C.
    Lazaro, M.
    Kazakova, E.
    Villa, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S1038 - S1039
  • [24] Clinicopathologic characteristics, genetic variability and therapeutic options of RET rearrangements patients in lung adenocarcinoma
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    LUNG CANCER, 2016, 101 : 16 - 21
  • [25] No patient left behind! Therapeutic options for cystic fibrosis patients living with lung transplantation
    Tissot, Adrien
    Burgel, Pierre-Regis
    JOURNAL OF CYSTIC FIBROSIS, 2022, 21 (05) : 735 - 736
  • [26] Therapeutic options in older patients with metastatic non-small cell lung cancer
    Quoix, Elisabeth
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2012, 4 (05) : 247 - 254
  • [27] Therapeutic options for elderly patients with advanced non-small cell lung cancer
    Avery, Eric J.
    Kessinger, Anne
    Ganti, Apar Kishor
    CANCER TREATMENT REVIEWS, 2009, 35 (04) : 340 - 344
  • [28] Clinicopathologic Characteristics, Genetic Variability and Therapeutic Options of RET Rearrangement Patients in Lung Adenocarcinoma
    Song, Zhengbo
    Yu, Xinmin
    Zhang, Yiping
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S963 - S964
  • [29] Therapeutic options in patients with locally advanced non-small cell lung cancer
    Lampridis, Savvas
    Minervini, Fabrizio
    Scarci, Marco
    FRONTIERS IN SURGERY, 2024, 11
  • [30] Validation of broad panel clinical sequencing-based genomic risk stratification in patients with advanced lung adenocarcinomas.
    Whipple, Sam
    Martin, Axel
    Martinec, Michael
    Arbour, Kathryn Cecilia
    Seshan, Venkatraman E.
    Riely, Gregory J.
    Crane, Gracy
    Shen, Ronglai
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
12345